
    
      A patients participation in the study will last for up to 4 years and will include up to nine
      visits:

        -  Screening (1 visit, same as HP-CD-CL-2003 End-of-Study visit)

        -  Pre-surgery / explantation surgery / post-surgery (3 visits)

        -  Safety (4 visits)

        -  DAT-PET (Dopamine Transporter - Positron Emission Tomography) examination (1 visit)

        -  End-of-study visit (1 visit)

      Study examinations and assessments:

        -  Physical examination: pulse rate, blood pressure, temperature, body weight and height,
           body mass index (BMI), neurological exam

        -  ECG (electrocardiography) and blood and urine tests

        -  Pregnancy tests for women of childbearing age

        -  Completion of a patient diary to record mobility and time asleep

        -  Parkinson's Kinetigraph (PKGTM) Data Logger: a watch-type movement recording device

        -  Questionnaires, rating scales and forms: quality of life, mood, memory, impulse control,
           mental health.

        -  Magnetic resonance imaging (MRI)

        -  Positron emission tomography scans (PET)

        -  Skin condition over any remaining implanted subcutaneous portion of the device.

        -  Skin healing after port / device removal.

      For more information: https://treater.eu/clinical-study/
    
  